Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications use oral corticosteroids risk acute myocardial infarction
… in COPD Patients Treated with Inhaled Bronchodilators Acute myocardial infarction, stroke, and MACE in COPD … evaluated cardiovascular safety endpoints related to the use of aclidinium. The study evaluated the risk of acute myocardial infarction, stroke, and other major …
… Determining Effectiveness of Risk-Minimization Measures Impact of Risk Minimization Measures on the Use of Cilostazol in Europe J Castellsague, B Calingaert , B … contraindicated in patients with unstable angina pectoris myocardial infarction or coronary intervention within the …
… Pharmacoepidemiology and Risk Management Regulatory Real-World Evidence Research Let … activities. To understand disease distribution, risk factors, treatment patterns and impact, comorbidities, … companies reduce the uncertainty of risks to patients who use their products. …
… Benefit-Risk Preferences Benefit-risk preference studies are a specific application of … provided with a set of actual treatment options. Benefit-risk preference studies demonstrate the net benefits of …
… Benefit-Risk Assessment Do your product’s benefits outweigh its … help you navigate the ever-evolving landscape of benefit-risk assessment and meet the requirements of regulatory and … and improved communication about your product’s benefit-risk profile. A Structured Approach Tailored to Your Needs …
… Heart transplantation Hypertension Hypotension Ischemia Myocardial infarction Peripheral arterial occlusion Peripheral edema … of CV illnesses. Recent projects have included: Benefit-risk preference studies Cohort and case-control studies …
… Using Primary Data Collection To meet the requirements of risk management programs, inform drug development and … of patients, physicians, and caregivers Evaluate risk management programs including REMS and EU-RMPs Depending …
Causal Inference for Regulatory-Grade RWE Among the hurdles for making your healthcare interventions available to patients is being able to meet regulatory requirements for estimating the product's safety and/or effectiveness using real-world data (RWD). …
… address a safety issue of regulatory importance within a risk management plan Designing studies to evaluate the effectiveness of risk minimization measures within a risk management plan … synopses and writing study protocols and analysis plans to use in regulatory discussions Advising on benefit-risk …
… in a disease area Economic model inputs including resource use, cost, and utility estimates Literature reviews often … to assess heterogeneity It is important that the best use of the available data in a network is achieved. This …